Amundi’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Buy
23,983
+9,148
+62% +$54.7K ﹤0.01% 1941
2025
Q4
$103K Buy
+14,835
New +$97.6K ﹤0.01% 1809
2025
Q2
Sell
-152
Closed -$862 1718
2025
Q1
$862 Sell
152
-20
-12% -$144 ﹤0.01% 2056
2024
Q4
$1.35K Buy
+172
New +$1.42K ﹤0.01% 2011
2022
Q4
Sell
-124,398
Closed -$943K 1906
2022
Q3
$943K Sell
124,398
-28,014
-18% -$195K ﹤0.01% 1254
2022
Q2
$1.33M Buy
152,412
+22,618
+17% +$316K ﹤0.01% 1128
2022
Q1
$3.02M Buy
129,794
+955
+0.7% +$23.3K ﹤0.01% 1064
2021
Q4
$3.45M Buy
128,839
+15,731
+14% +$421K ﹤0.01% 1097
2021
Q3
$3.15M Buy
113,108
+6,373
+6% +$181K ﹤0.01% 1116
2021
Q2
$3.13M Buy
+106,735
New +$3.23M ﹤0.01% 1089

Other funds holding BHC

Amundi's BHC Position: Q1 2026 in Review

Amundi increased its Bausch Health (BHC) stake by 62% in Q1 2026, buying an estimated $54.7K and bringing the position to 23,983 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1941.

Amundi first reported a position in BHC in Q2 2021 and has held it in 10 quarters since. The position peaked at $3.45M in Q4 2021. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Amundi held 23,983 shares of Bausch Health worth $130K as of Q1 2026.
  • Amundi bought 9,148 Bausch Health shares in Q1 2026, an estimated $54.7K.
  • Bausch Health made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1941 holding.
  • Amundi first reported a position in Bausch Health in Q2 2021 and has held it in 10 quarters since.
  • Amundi's Bausch Health position peaked at $3.45M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.